Evidence map›Paper›PMID 33580673›Full record

ArticleEuropean heart journal2021

Genetic insight into sick sinus syndrome.

Rosa B Thorolfsdottir, Gardar Sveinbjornsson, Hildur M Aegisdottir, Stefania Benonisdottir, Lilja Stefansdottir, Erna V Ivarsdottir, Gisli H Halldorsson, Jon K Sigurdsson, Christian Torp-Pedersen, Peter E Weeke and 35 more

Open access · bronzeAbstract read
In one paragraph

Article in European heart journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Deciphering epistatic genetic regulation of cardiac hypertrophy.medRxiv : the preprint server for health sciences · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Familial risk of sinus node dysfunction indicating pacemaker implantation: a nationwide cohort study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  14. Increased pacemaker implantation and mortality rates in relatives of patients with early-onset sinus node dysfunction: can genetics explain all?Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors at 13 institutions in 4 countries.

Rosa B ThorolfsdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0001-7475-0398
Gardar SveinbjornssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0003-2429-9468
Hildur M AegisdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Stefania BenonisdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0001-5019-514X
Lilja StefansdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Erna V IvarsdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0002-2069-0681
Gisli H HalldorssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0001-7067-9862
Jon K SigurdssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Christian Torp-PedersenDepartment of Clinical Research and Cardiology, Nordsjaelland Hospital, Dyrehavevej 29, Hillerød 3400, Denmark.ORCID 0000-0003-2892-6131
Peter E WeekeDepartment of Cardiology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.
Søren BrunakNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3A, Copenhagen 2200, Denmark.
David WestergaardNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3A, Copenhagen 2200, Denmark.ORCID 0000-0003-0128-8432
Ole B PedersenDepartment of Clinical Immunology, Naestved Hospital, Ringstedgade 77B, Naestved 4700, Denmark.ORCID 0000-0003-2312-5976
Erik SorensenDepartment of Clinical Immunology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.
Kaspar R NielsenDepartment of Clinical Immunology, Aalborg University Hospital North, Urbansgade 36, Aalborg 9000, Denmark.ORCID 0000-0003-4406-9643
Kristoffer S BurgdorfDepartment of Clinical Immunology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.ORCID 0000-0001-5814-6844
Karina BanasikNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3A, Copenhagen 2200, Denmark.ORCID 0000-0003-2489-2499
Ben BrumptonDepartment of Thoracic and Occupational Medicine, St. Olavs Hospital, Trondheim University Hospital, Prinsesse Kristinas gate 3, Trondheim 7030, Norway.ORCID 0000-0002-3058-1059
Wei ZhouDepartment of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218, USA.ORCID 0000-0001-7719-0859
Asmundur OddssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0002-4606-5163
Vinicius TragantedeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0002-8223-8957
Kristjan E HjorleifssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0002-7851-1818
Olafur B DavidssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Sridharan RajamanideCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Stefan JonssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Bjarni TorfasonFaculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.
Atli S ValgardssonDepartment of Cardiothoracic Surgery, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.
Gudmundur ThorgeirssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Michael L FriggedeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Gudmar ThorleifssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0003-4623-9087
Gudmundur L NorddahldeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Anna HelgadottirdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Solveig GretarsdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Patrick SulemdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0001-7123-6123
Ingileif JonsdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0001-8339-150X
Cristen J WillerDepartment of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218, USA.ORCID 0000-0001-5645-4966
Kristian HveemK.G. Jebsen Center for Genetic Epidemiology, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Erling Skjalgssons gt. 1, Trondheim 7491, Norway.
Henning BundgaardDepartment of Cardiology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.
Henrik UllumDepartment of Clinical Immunology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.ORCID 0000-0001-7306-9058
David O ArnardeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Unnur ThorsteinsdottirdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0002-7049-2827
Daniel F GudbjartssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0002-5222-9857
Hilma HolmdeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0002-9517-6636
Kari StefanssondeCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.ORCID 0000-0003-1676-864X
DBDS Genomic Consortium
deCODE Genetics (Iceland) · ISCopenhagen University Hospital · DKUniversity of Copenhagen · DKNordsjællands Hospital · DKStatens Serum Institut · DKWashtenaw Community College · USAalborg University Hospital · DKCalifornia Institute of Technology · USNæstved Sygehus · DKNational University Hospital of Iceland · ISNorwegian University of Science and Technology · NOSt Olav's University Hospital · NOUniversity of Iceland · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aim of this study was to use human genetics to investigate the pathogenesis of sick sinus syndrome (SSS) and the role of risk factors in its development. METHODS AND

resultsWe performed a genome-wide association study of 6469 SSS cases and 1 000 187 controls from deCODE genetics, the Copenhagen Hospital Biobank, UK Biobank, and the HUNT study. Variants at six loci associated with SSS, a reported missense variant in MYH6, known atrial fibrillation (AF)/electrocardiogram variants at PITX2, ZFHX3, TTN/CCDC141, and SCN10A and a low-frequency (MAF = 1.1-1.8%) missense variant, p.Gly62Cys in KRT8 encoding the intermediate filament protein keratin 8. A full genotypic model best described the p.Gly62Cys association (P = 1.6 × 10-20), with an odds ratio (OR) of 1.44 for heterozygotes and a disproportionally large OR of 13.99 for homozygotes. All the SSS variants increased the risk of pacemaker implantation. Their association with AF varied and p.Gly62Cys was the only variant not associating with any other arrhythmia or cardiovascular disease. We tested 17 exposure phenotypes in polygenic score (PGS) and Mendelian randomization analyses. Only two associated with the risk of SSS in Mendelian randomization, AF, and lower heart rate, suggesting causality. Powerful PGS analyses provided convincing evidence against causal associations for body mass index, cholesterol, triglycerides, and type 2 diabetes (P > 0.05).

conclusionWe report the associations of variants at six loci with SSS, including a missense variant in KRT8 that confers high risk in homozygotes and points to a mechanism specific to SSS development. Mendelian randomization supports a causal role for AF in the development of SSS.

Indexed as

Atrial FibrillationDiabetes Mellitus, Type 2Pacemaker, ArtificialGenome-Wide Association StudyHumansNAV1.8 Voltage-Gated Sodium ChannelSick Sinus SyndromeNAV1.8 Voltage-Gated Sodium ChannelSCN10A protein, humanAtrial fibrillationGWASKRT8Mendelian randomizationSick sinus syndrome

Identifiers

PMID33580673
PMCPMC8140484
OpenAlexW3127897185

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.